The U.S. government is spending far too little on efforts to commercialize quantum technologies. Its SBIR and STTR programs ...

The biggest hurdle for AirJoule Technologies (NASDAQ: AIRJ) and its investors is the transition to commercialization, but it looks to be an easy hurdle to cross. The fiscal Q4 results reveal the ...

Company expands product platform, strengthens balance sheet, advances strategic partnerships, and positions AquaRefining™ for ...

YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...

The successful commercialization of innovative medical technologies remains a cornerstone of advancing healthcare delivery and patient outcomes. The journey from a novel concept to a market-ready ...

Quantum technology firms are braving turbulent markets to publicly list this year, as the nascent industry looks towards ...

WASHINGTON - The director of the Purdue Office of Technology and Commercialization (OTC) on Wednesday (July 24) testified before a congressional panel examining ways to improve technology transfer at ...

RICHMOND, VA, UNITED STATES, October 8, 2024 /EINPresswire.com/ -- The Virginia Innovation Partnership Corporation (VIPC) today announced that Blacksburg, Virginia ...

Former Hologic executive brings nearly two decades of success in hospital sales and commercialization expertise to medical technology leader's board CARLSBAD, Calif., Feb. 25, 2026 /PRNewswire/ -- ...

Generated Cash from Non-Core Asset Sales: Completed the $4.3 million sale of the Sierra ARC facility and sold $200,000 in non-core equipment. Strengthened Balance Sheet: Eliminated all long-term debt.

Builds on momentum following appointment of CEO and completion of Phase III clinical trials for PlasmaCap IG (Intravenous Immunoglobulin or “IVIG”) MISSISSAUGA, Ontario--(BUSINESS WIRE)--Evolve ...